Infimab Injection 1's

Infimab Injection 1's belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors that help reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, plaque psoriasis, and psoriatic arthritis. This medicine is also used in the treatment of Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and uveitis.

Infimab Injection 1's consists of Infliximab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused by various autoimmune diseases.

Infimab Injection 1's may cause certain side effects such as nausea, headache, back pain, upper respiratory tract infections, vision problems, dizziness, pale skin, numbness, chest pain, rash, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Infimab Injection 1's is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. 

Infimab Injection 1's may not be suitable for all. Inform your doctor if you are allergic to any of its components. Tell your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, hepatitis B virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system before taking Infimab Injection 1's, as it can worsen your condition. Infimab Injection 1's may cause dizziness, so drive only if you are alert and focused. Infimab Injection 1's should not be given to children under two years of age as safety has not been established. Inform the doctor if you are pregnant or breastfeeding beforehand.

Infimab Injection 1's consists of Infliximab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. Infimab Injection 1's works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

Infimab Injection 1's should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, hepatitis B virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), or diabetes while taking this medicine, as it can worsen these conditions. Lymphomas and other malignancies were reported in children and adolescents treated with Infimab Injection 1's. Hence, it should be used with caution. Do not take live vaccines while being treated with Infimab Injection 1's to prevent any serious consequences. Infimab Injection 1's is not recommended for use in children below six years of age as safety and efficacy are not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.

• It is advised to closely monitor the patient for infections like active tuberculosis during and after the treatment, though the patient gets a negative tuberculin test.
• It is essential to inform your doctor if you have any active viral, bacterial, and fungal infections before starting Infimab Injection 1's.